Hematology

A 5 year observational study (registry) of children aged 2 to <6 years at enrollment with transfusional hemosiderosis treated with deferasirox (IRB# 25075)

Status: Active

Investigators:

  • Andrew S. Freiberg, M.D.

Categories:

  • Hematology
  • Transfusional Hemosiderosis
 

Rituxan Off-Label Use Registry (IRB# 29270EP)

Status: Active

Investigators:

  • Principal Investigator: Andrew S. Freiberg, MD

Categories:

  • Hematology / Oncology
 

CINV - An open-label, cross-over, pharmacokinetic study to assess the safety and pharmacokinetics of transdermal granisetron (Sancuso® patch) and IV granisetron in a pediatric oncology population (aged 13 to 17 years) - 392MD/44/C (IRB# 39992)

Status: Active

Investigators:

  • Principal Investigator: Andrew S. Freiberg, M.D.

Categories:

  • Hematology / Oncology
 

09MRD - The Role of Minimal Residual Disease Testing before and after Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia (IRB# 38709)

Status: Active

Investigators:

  • Principal Investigator: Robert J. Greiner, M.D.

Categories:

  • Hematology / Oncology
 

CV185118 - Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects at Risk for a Venous or Arterial Thrombotic Disorder (IRB# 41107)

Status: Active

Investigators:

  • Principal Investigator: Andrew S. Freiberg, MD

Categories:

  • Hematology / Oncology